Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Sponsor: Definium Therapeutics US, Inc.
Summary
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Voyage
Official title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Voyage
Key Details
Gender
All
Age Range
18 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-12-11
Completion Date
2026-11
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
Placebo
A substance that is designed to have no therapeutic value
MM120 (LSD D-Tartrate)
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
Locations (36)
Lighthouse Psychiatry
Gilbert, Arizona, United States
Scottsdale Research Institute
Scottsdale, Arizona, United States
Kadima Neuropsychiatry Institute
La Jolla, California, United States
UCSF Department of Neurology
San Francisco, California, United States
Psychedelic Science Institute
Santa Monica, California, United States
Mountain View
Denver, Colorado, United States
Clinical Neuroscience Solutions Inc.
Jacksonville, Florida, United States
Accel Research Sites - Lakeland CRU
Lakeland, Florida, United States
Segal Trials
Lauderhill, Florida, United States
Atlanta Center for Medical Research
Atlanta, Georgia, United States
iResearch Atlanta
Decatur, Georgia, United States
CenExel iResearch, LLC
Savannah, Georgia, United States
Uptown Research Institute
Chicago, Illinois, United States
Adams Clinical Boston
Boston, Massachusetts, United States
Adams Clinical Watertown
Watertown, Massachusetts, United States
University of Missouri Health Care
Columbia, Missouri, United States
Hassman Research Institute
Marlton, New Jersey, United States
Spectrum Neuroscience and Treatment Institute
New York, New York, United States
Adams Clinical Harlem
New York, New York, United States
New York State Psychiatric Institute (NYSPI)
New York, New York, United States
Adams Clinical Bronx
The Bronx, New York, United States
Cleveland Clinic Lutheran Hospital
Cleveland, Ohio, United States
Summit Headlands LLC
Portland, Oregon, United States
Scranton Medical Institute
Moosic, Pennsylvania, United States
Adams Clinical Philadelphia
Philadelphia, Pennsylvania, United States
Coastal Carolina Research Center
North Charleston, South Carolina, United States
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
University of Texas at Austin
Austin, Texas, United States
Austin Clinical Trial Partners
Austin, Texas, United States
BioBehavioral Research of Austin
Austin, Texas, United States
FutureSearch Trials of Dallas, LLC
Dallas, Texas, United States
Adams Clinical Dallas
DeSoto, Texas, United States
Cedar Clinical Research
Draper, Utah, United States
Inner Space Research
Orem, Utah, United States
Memory Clinic Inc.
Bennington, Vermont, United States
Seattle Neuropsychiatric Treatment Center
Seattle, Washington, United States